| [1] |
Arvin AM，Greenberg HB.New viral vaccines[J].Virology,2006,344(1):240-9.
|
| [2] |
But DY，Lai CL,Yuen MF.Natural history of hepatitis-related hepatocellular carcinoma[J].WorldJ Gastroenterol,2008,14(11):1652-6.
|
| [3] |
Maddrey WC.Hepatitis B--an important public health issue[J].Clin Lab,2001,47(1-2):51-5.
|
| [4] |
Yang ZT，Zhang XX，Kong XF，et al.Polymorphisms of microsomal triglyceride transfer protein indifferent hepatitis B virus-infected patients[J].World J Gastroenterol,2008,14(35):5454-60.
|
| [5] |
Wu X，Zhu X，Zhu S,et al.A pharmacogenetic study of polymorphisms in interferon pathway genesand response to interferon-alpha treatment in chronic hepatitis B patients[J].Antiviral Res，2009，83(3):252-6.
|
| [6] |
Zhu X,Chen MS,Tian LW,et al.Single nucleotide polymorphism of rs430397 in the fifth intron ofGRP78 gene and clinical relevance of primary hepatocellular carcinoma in Han Chinese:risk andprognosis [J]Int J Cancer,2009,125(6):1352-7.
|
| [7] |
Chiang PC,Hsu JL,Yeh TC,et al.Elucidation of susceptible factos to endoplasmic reticulumstress-mediated anticancer activity in human hepatocellular carcinoma[J].Naunyn-Schmiedebergs ArchPharmacol,2008,377(2):167-77.
|
| [8] |
Lim SO，Park SG，Yoo JH,et al.Expression of heat shock proteins(HSP27，HSP60，HSP70，HSP90，GRP78，GRP94) in hepatitis B virus-related hepatocellular carcinomas and dysplastic nodules[J].World J Gastroenterol,2005,11(14):2072-9.
|
| [9] |
Cho DY,Yang GH,Ryu CJ,et al.Molecular chaperone GRP78/BiP interacts with the large surfaceprotein of hepatitis B virus in vitro and in vivo [J].J Virol,2003,77(4):2784-8.
|
| [10] |
Huang KL,Lai YK,Lin CC,et al.Involvement of GRP78 in inhibition of HBV secretion by Boehmerianivea extract in human HepG2 2.2.15 cells [J].J Viral Hepat,2009,16(5):367-75.
|
| [11] |
Awe K，Lambert C，Prange R.Mammalian BiP controls posttranslational ER translocation of thehepatitis B virus large envelope protein[J].FEBS lett,2008,582(21-22):3179-84.
|
| [12] |
Assy N,Beniashvili Z,Djibre A,et al.Lower baseline ALT cut-off values and HBV DNA levelsbetter differentiate HBeAg- chronic hepatitis B patients from inactive chronic carriers[J].World JGastroenterol,2009,15(24):3025-31.
|
| [13] |
Nash KL，Alexander GJ.The case for combination antiviral therapy for chronic hepatitis B virusinfection[J].Lancet Infect Dis,2008,8(7):444-8.
|
| [14] |
Jakobsdottir J，Gorin MB，Conley YP,et al.Interpretation of genetic associationstudies:markers with replicated highly significant odds ratios may be poor classifiers[J].PLoSGenet,2009,5(2):e1000337.
|
| [15] |
Wang NT,Chen XC,Zhu BH.Occurrence mechanism of HBV related hepatocellular carcinoma[J].GuoJi Bing Du Xue Za Zhi,2010,17(6):178-83.[王兰天，陈心春，祝葆华.乙肝病毒相关性肝细胞癌发生机制[J].国际病毒学杂志，2010，17（6）：178-83.]
|
| [16] |
Shin HD，Park BL，Cheong HS,et al.SPP1 polymorphisms associated with HBV clearance and HCCoccurrence[J].Int J Epidemiol,2007,36(5):1001-8.
|
| [17] |
Lei RX,Shi H,Peng XM,et al.Influence of a single nucleotide polymorphism in the P1 promoter ofthe furin gene on transcription activity and hepatitis B virus infection[J].Hepatology,2009,50(3):763-71.
|
| [18] |
Uckun FM,Qazi S,Ozer Z,et al.Inducing apoptosis in chemotherapy-resistant B-lineage acutelymphoblastic leukaemia cells by targeting HSPA5，a master regulator of the anti-apoptotic unfoldedprotein response signalling network[J].Br J Haematol,2011,153(6):741-52.
|
下载:
